Lantus ® (“Lantus”) is Sanofi’s insulin glargine product. The U.S. Food and Drug Administration (FDA) first approved Lantus in 2000 as a sterile solution of insulin glargine for use as an injection.
The Bangalore District Chemists and Druggists Association (BDCDA) has alerted its trade fraternity about theft of Lantus SoloStar (Insulin Glargine Injection IP, r-DNA origin, 100 IU/mL), Batch No.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results